lithium carbonate has been researched along with pyruvic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheren'ko, MP; Radlovskaia, ZT; Shchepotin, IB | 1 |
| Allagui, MS; Croute, F; Desmoulin, F; Feki, AE; Murat, JC; Nciri, R; Vincent, C | 1 |
2 other study(ies) available for lithium carbonate and pyruvic acid
| Article | Year |
|---|---|
[Respiratory enzyme activity in the thyroid tissue of toxic goiter patients receiving lithium carbonate before surgery].
Topics: Cytochrome Reductases; Goiter, Nodular; Graves Disease; Humans; Iodide Peroxidase; Lactates; Lactic Acid; Lithium; Lithium Carbonate; Methimazole; NADH Dehydrogenase; Oxidation-Reduction; Preoperative Care; Pyruvates; Pyruvic Acid; Succinate Dehydrogenase; Thyroid Gland; Thyroidectomy | 1985 |
Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress.
Topics: Analysis of Variance; Cell Line, Tumor; Dose-Response Relationship, Drug; Extracellular Fluid; Glutathione; Glycolysis; Humans; Lipid Peroxidation; Lithium Carbonate; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Pyruvic Acid; Thiobarbituric Acid Reactive Substances; Time Factors | 2013 |